| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Fiztasovimab | NPC-21 | Phase 2 Clinical | Nobelpharma Co Ltd | Cytomegalovirus Infections | Details |
| TRL-345 | CMV-345; TRL-345 | Phase 1 Clinical | Trellis Bioscience LLC | Cytomegalovirus Infections | Details |